companies that manufacture glp-1 medications The push to make weight-loss drugs more affordable is running into legal limits. Telehealth company Hims & Hers pulled a less expensive oral version of Wegovy after lawsuits from Novo Nordisk and Feds, Pharma Companies Strike Deal

doi: 10.1016/j.conctc.2024.101424 53

Gather your supplies first

Read more #drugdevelopment #genericdrugs To view or add a comment, sign in "Both generic and brand-name drug manufacturers could promote measures to distinguish trustworthy GLP-1 products from substandard or unsafe alternatives," writes PRI's Sally Pipes

The promise of GLP-1s to address these concerns is understandably appealing, but we lack adequate research to guide evidence-based prescribing and patient decisionmaking for this population

Most countries allow personal-use injectable medications with proper documentation

The same results were confirmed by the study of Kuna et al